113 related articles for article (PubMed ID: 23611304)
1. Characteristics of primary cutaneous lymphoma according to WHO-EORTC classification in Korea.
Lee JH; Lee JH; Yoo DS; Kang H; Kim GM; Park HJ; Park CJ; Lee JD; Lee JY; Kim SY
Clin Exp Dermatol; 2013 Jul; 38(5):457-63. PubMed ID: 23611304
[TBL] [Abstract][Full Text] [Related]
2. World Health Organization-European Organization for Research and Treatment of Cancer classification of cutaneous lymphoma in Korea: a retrospective study at a single tertiary institution.
Park JH; Shin HT; Lee DY; Lee JH; Yang JM; Jang KT; Ko YH
J Am Acad Dermatol; 2012 Dec; 67(6):1200-9. PubMed ID: 22521781
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
Yasukawa K; Kato N; Kodama K; Hamasaka A; Hata H
J Cutan Pathol; 2006 Jul; 33(7):487-91. PubMed ID: 16872471
[TBL] [Abstract][Full Text] [Related]
4. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
[TBL] [Abstract][Full Text] [Related]
5. Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification.
Yoon SO; Suh C; Lee DH; Chi HS; Park CJ; Jang SS; Shin HR; Park BH; Huh J
Am J Hematol; 2010 Oct; 85(10):760-4. PubMed ID: 20806229
[TBL] [Abstract][Full Text] [Related]
6. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Lymphoma in Korea: A Nationwide Retrospective Study.
Lee HS; Suh KS; Lee DY; Cho KH; Oh SH; Kim SC; Lee SJ; Shin DH; Yoon TY; Won YH; Kim YC
Acta Derm Venereol; 2016 May; 96(4):535-9. PubMed ID: 26560051
[TBL] [Abstract][Full Text] [Related]
8. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
[TBL] [Abstract][Full Text] [Related]
9. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
10. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
11. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases.
Plaza JA; Kacerovska D; Stockman DL; Buonaccorsi JN; Baillargeon P; Suster S; Kazakov DV
Am J Dermatopathol; 2011 Oct; 33(7):649-55; quiz 656-8. PubMed ID: 21937906
[TBL] [Abstract][Full Text] [Related]
12. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
Acta Derm Venereol; 2011 Sep; 91(5):521-5. PubMed ID: 21547335
[TBL] [Abstract][Full Text] [Related]
13. [Incidence and histologic patterns of bone marrow involvement of malignant lymphoma based on the World Health Organization classification: a single institution study].
Jeong SY; Chang YH; Lee JK; Hong YJ; Hong SI; Lee SS
Korean J Lab Med; 2007 Dec; 27(6):383-7. PubMed ID: 18160826
[TBL] [Abstract][Full Text] [Related]
14. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan.
Chen WL; Tsai WC; Chao TY; Sheu LF; Chou JM; Kao WY; Chen YC; Ho CL
Ann Hematol; 2010 Jun; 89(6):553-62. PubMed ID: 20012434
[TBL] [Abstract][Full Text] [Related]
16. Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study.
Maurelli M; Tessari G; Colato C; Schena D; Girolomoni G
Eur J Dermatol; 2018 Feb; 28(1):44-49. PubMed ID: 29171395
[TBL] [Abstract][Full Text] [Related]
17. Non-mycosis fungoides cutaneous T-cell lymphoma: reclassification according to the WHO-EORTC classification.
Weaver J; Mahindra AK; Pohlman B; Jin T; Hsi ED
J Cutan Pathol; 2010 May; 37(5):516-24. PubMed ID: 20132421
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
[TBL] [Abstract][Full Text] [Related]
19. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems.
Smith BD; Glusac EJ; McNiff JM; Smith GL; Heald PW; Cooper DL; Wilson LD
J Clin Oncol; 2004 Feb; 22(4):634-9. PubMed ID: 14966086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
